1.Bray, F, Ferlay, J, Soerjomataram, I, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394–424.
2.Coburn, SB, Bray, F, Sherman, ME, et al. (2017) International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer 140, 2451–2460.
3.Lee, JY, Kim, S, Kim, YT, et al. (2018) Changes in ovarian cancer survival during the 20 years before the era of targeted therapy. BMC Cancer 18, 601.
4.Reid, BM, Permuth, JB & Sellers, TA (2017) Epidemiology of ovarian cancer: a review. Cancer Biol Med 14, 9–32.
5.Nicklas, TA, O’Neil, CE & Fulgoni, VL, 3rd (2009) The role of dairy in meeting the recommendations for shortfall nutrients in the American diet. J Am Coll Nutr 28, Suppl. 1, 73S–81S.
6.Bermejo, LM, Lopez-Plaza, B, Santurino, C, et al. (2019) Milk and dairy product consumption and bladder cancer risk: a systematic review and meta-analysis of observational studies. Adv Nutr 10, S224–S238.
7.Thorning, TK, Raben, A, Tholstrup, T, et al. (2016) Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence. Food Nutr Res 60, 32527.
8.Fleet, JC, DeSmet, M, Johnson, R, et al. (2012) Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441, 61–76.
9.Khandwala, HM, McCutcheon, IE, Flyvbjerg, A, et al. (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21, 215–244.
10.Coppola, D, Saunders, B, Fu, L, et al. (1999) The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression. Cancer Res 59, 3264–3270.
11.World Cancer Research Fund/American Institute for Cancer Research (2018) Continuous Update Project Expert Report 2018. Diet, Nutrition, Physical, Activity and Ovarian Cancer. http://dietandcancerreport.org (accessed October 2019).
12.Liu, J, Tang, W, Sang, L, et al. (2015) Milk, yogurt, and lactose intake and ovarian cancer risk: a meta-analysis. Nutr Cancer 67, 68–72.
13.Genkinger, JM, Hunter, DJ, Spiegelman, D, et al. (2006) Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 15, 364–372.
14.Larsson, SC, Orsini, N & Wolk, A (2006) Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Int J Cancer 118, 431–441.
15.Song, X, Li, Z, Ji, X, et al. (2017) Calcium intake and the risk of ovarian cancer: a meta-analysis. Nutrients 9, 679–694.
16.Cook, LS, Neilson, HK, Lorenzetti, DL, et al. (2010) A systematic literature review of vitamin D and ovarian cancer. Am J Obstet Gynecol 203, 70.e1–e8.
17.Stang, A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603–605.
18.Greenland, S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9, 1–30.
19.Riley, RD, Higgins, JP & Deeks, JJ (2011) Interpretation of random effects meta-analyses. BMJ 342, d549.
20.Zheng, W, Danforth, KN, Tworoger, SS, et al. (2010) Circulating 25-Hydroxyvitamin D and risk of epithelial ovarian cancer. Am J Epidemiol 172, 70–80.
21.Hamling, J, Lee, P, Weitkunat, R, et al. (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27, 954–970.
22.Higgins, JP & Thompson, SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539–1558.
23.Greenland, S & Longnecker, MP (1992) Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 135, 1301–1309.
24.Orsini, N, Bellocco, R & Greenland, S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stata J 6, 40–57.
25.Chen, GC, Qin, LQ & Ye, JK (2014) Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes Rev 15, 134–142.
26.Ding, M, Bhupathiraju, SN, Satija, A, et al. (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose–response meta-analysis of prospective cohort studies. Circulation 129, 643–659.
27.Wang, X, Ouyang, Y, Liu, J, et al. (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose–response meta-analysis of prospective cohort studies. BMJ 349, g4490.
28.Egger, M, Davey Smith, G, Schneider, M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634.
29.La Vecchia, C, Decarli, A, Negri, E, et al. (1987) Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst 79, 663–669.
30.Mettlin, CJ & Piver, MS (1990) A case–control study of milk-drinking and ovarian cancer risk. Am J Epidemiol 132, 871–876.
31.Engle, A, Muscat, JE & Harris, RE (1991) Nutritional risk factors and ovarian cancer. Nutr Cancer 15, 239–247.
32.Risch, HA, Jain, M, Marrett, LD, et al. (1994) Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Cause Control 5, 540–548.
33.Webb, PM, Bain, CJ, Purdie, DM, et al. (1998) Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Cause Control 9, 637–644.
34.Bertone, ER, Hankinson, SE, Newcomb, PA, et al. (2001) A population-based case–control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Cause Control 12, 83–90.
35.Bosetti, C, Negri, E, Franceschi, S, et al. (2001) Diet and ovarian cancer risk: a case–control study in Italy. Int J Cancer 93, 911–915.
36.Goodman, MT, Wu, AH, Tung, KH, et al. (2002) Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156, 148–157.
37.Salazar-Martinez, E, Lazcano-Ponce, EC, Lira-Lira, GG, et al. (2002) Nutritional determinants of epithelial ovarian cancer risk: a case–control study in Mexico. Oncology 63, 151–157.
38.Zhang, M, Yang, ZY, Binns, CW, et al. (2002) Diet and ovarian cancer risk: a case–control study in China. Br J Cancer 86, 712–717.
39.McCann, SE, Freudenheim, JL, Marshall, JR, et al. (2003) Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 133, 1937–1942.
40.Pan, SY, Ugnat, AM, Mao, Y, et al. (2004) A case–control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13, 1521–1527.
41.Kiani, F, Knutsen, S, Singh, P, et al. (2006) Dietary risk factors for ovarian cancer: the adventist health study (United States). Cancer Cause Control 17, 137–146.
42.Park, Y, Leitzmann, MF, Subar, AF, et al. (2009) Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern Med 169, 391–401.
43.Faber, MT, Jensen, A, Søgaard, M, et al. (2012) Use of dairy products, lactose, and calcium and risk of ovarian cancer results from a Danish case–control study. Acta Oncologica 51, 454–464.
44.Merritt, MA, Cramer, DW, Vitonis, AF, et al. (2013) Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes. Int J Cancer 132, 1114–1124.
45.Gallus, S, Bravi, F, Talamini, R, et al. (2006) Milk, dairy products and cancer risk (Italy). Cancer Cause Control 17, 429–437.
46.Qin, B, Moorman, PG, Alberg, AJ, et al. (2016) Dairy, calcium, Vitamin D and ovarian cancer risk in African-American women. Br J Cancer 115, 1122–1130.
47.Kushi, LH, Mink, PJ, Folsom, AR, et al. (1999) Prospective study of diet and ovarian cancer. Am J Epidemiol 149, 21–31.
48.Larsson, SC, Bergkvist, L & Wolk, A (2004) Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 80, 1353–1357.
49.Koralek, DO, Bertone-Johnson, ER, Leitzmann, MF, et al. (2006) Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 56, 22–30.
50.Mommers, M, Schouten, LJ, Goldbohm, RA, et al. (2006) Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on diet and cancer. Br J Cancer 94, 165–170.
51.Chang, ET, Lee, VS, Canchola, AJ, et al. (2007) Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 165, 802–813.
52.Bidoli, E, Vecchia, CL, Talamini, R, et al. (2001) Micronutrients and ovarian cancer: a case–control study in Italy. Ann Oncol 12, 1589–1593.
53.Toriola, AT, Surcel, HM, Calypse, A, et al. (2010) Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case–control study. Eur J Cancer 46, 2799–2805.
54.Merritt, MA, Poole, EM, Hankinson, SE, et al. (2014) Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer. Cancer Cause Control 25, 795–808.
55.Cramer, DW, Kuper, H, Harlow, BL, et al. (2001) Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women. Int J Cancer 94, 128–134.
56.Tworoger, SS, Lee, IM, Buring, JE, et al. (2007) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 16, 783–788.
57.Arslan, AA, Clendenen, TV, Koenig, KL, et al. (2009) Circulating vitamin d and risk of epithelial ovarian cancer. J Oncol 2009, 672492.
58.Qin, LQ, Xu, JY, Wang, PY, et al. (2005) Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies. Eur J Cancer Prev 14, 13–19.
59.Cramer, DW, Welch, WR, Hutchison, GB, et al. (1984) Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 63, 833–838.
60.Qiu, W, Lu, H, Qi, Y, et al. (2016) Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Oncotarget 7, 37390–37406.
61.Ganmaa, D & Sato, A (2005) The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Med Hypotheses 65, 1028–1037.
62.Qin, LQ, He, K, Xu, JY (2009) Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review. Int J Food Sci Nutr 60, Suppl. 7, 330–340.
63.Yin, L, Grandi, N, Raum, E, et al. (2011) Meta-analysis: circulating vitamin D and ovarian cancer risk. Gynecol Oncol 121, 369–375.
64.Hostmark, AT & Lunde, MS (2012) Cheese can reduce indexes that estimate fatty acid desaturation. Results from the Oslo Health Study and from experiments with human hepatoma cells. Appl Physiol Nutr Metab 37, 31–39.
65.Marco, ML, Heeney, D, Binda, S, et al. (2017) Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 44, 94–102.
66.Vinusha, KS, Deepika, K, Johnson, TS, et al. (2018) Proteomic studies on lactic acid bacteria: a review. Biochem Biophys Rep 14, 140–148.
67.Zhang, K, Dai, H, Liang, W, et al. (2019) Fermented dairy foods intake and risk of cancer. Int J Cancer 144, 2099–2108.
68.McCarty, MF (2000) Parathyroid hormone may be a cancer promoter – an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses 54, 475–482.
69.Coxam, V, Davicco, MJ, Durand, D, et al. (1992) The influence of parathyroid hormone-related protein on hepatic IGF-1 production. Acta Endocrinol (Copenh) 126, 430–433.
70.Guo, H, Guo, J, Xie, W, et al. (2018) The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention. J Ovarian Res 11, 71.
71.Peterlik, M, Grant, WB & Cross, HS (2009) Calcium, vitamin D and cancer. Anticancer Res 29, 3687–3698.
72.Lips, P (2012) Interaction between vitamin D and calcium. Scand J Clin Lab Invest Suppl 243, 60–64.
73.Subramanian, A & Gernand, AD (2019) Vitamin D metabolites across the menstrual cycle: a systematic review. BMC Womens Health 19, 19.
74.Hochberg, Z & Hochberg, I (2019) Evolutionary perspective in rickets and vitamin D. Front Endocrinol (Lausanne) 10, 306.
75.Liu, G, Hale, GE & Hughes, CL (2000) Galactose metabolism and ovarian toxicity. Reprod Toxicol 14, 377–384.
76.Xu, YK, Ng, WG, Kaufman, FR, et al. (1989) Galactose metabolism in human ovarian tissue. Pediatr Res 25, 151–155.
77.Cramer, DW, Harlow, BL, Willett, WC, et al. (1989) Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 2, 66–71.
78.Kaufman, FR, Kogut, MD, Donnell, GN, et al. (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304, 994–998.
79.Cramer, DW (1990) Epidemiologic aspects of early menopause and ovarian cancer. Ann N Y Acad Sci 592, 363–375; discussion 390–364.